⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TEM News
Tempus AI, Inc. Class A Common Stock
Tempus Receives IVDR Certification for xR RNA Sequencing for Solid Tumor Profiling
businesswire.com
TEM
Form 8-K
sec.gov
TEM
Tempus Presents Data Demonstrating AI-Enabled Pre-Screening Can Help Identify Patients for Biomarker Testing in NSCLC
businesswire.com
TEM
The $1 Trillion AI Healthcare Revolution: A New Era of Medical Innovation Is Taking Shape
globenewswire.com
TEM
IQV
Global AI Medical Devices Market Size, Share, and Trends Analysis - Industry Forecast 2026-2036 | Precision Diagnostics, Remote Monitoring, and Generative AI Fuel Strategic Growth
globenewswire.com
GEHC
PHG
MDT
ABT
MSFT
TEM
Ambry Genetics Announces GenomeNext™, a Whole Genome Sequencing Test Solution to Improve Diagnosis for Rare Diseases
businesswire.com
TEM
Tempus Announces Multi-Year Collaboration with Moderna and Merck
businesswire.com
TEM
MRK
MRNA
AI Drug Discovery Forecasts Vary Widely as Sector Shifts to Deployment
prnewswire.com
ABCL
HYFT
TEM
LLY
MU
TWST
AI Drug Discovery Market Projected to Reach $13.8 Billion by 2033
prnewswire.com
MRNA
HYFT
SDGR
TEM
PLTR
Tempus Launches Effort to Build the Largest Multimodal Whole-Genome Dataset to Advance AI-Driven Healthcare Innovation
businesswire.com
TEM